Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

Keyphrases

• Idiopathic Parkinson's Disease 100%
• Disease Groups 100%
• Parkinson's Disease 83%
• Pathogenic Variants 50%
• Clinical Data 50%
• Leucine-rich Repeat Kinase 2 (LRRK2) 50%
• VPS35 50%
• Genetic Data 33%
• DJ-1 33%
• International Cohort 33%
• Clinical Trials 16%
• Countries Worldwide 16%
• Clinical Characterization 16%
• Online Survey 16%
• Number of Subjects 16%
• Demographic Data 16%
• Individual-level Data 16%
• Small Fraction 16%
• Risk Variant 16%
• Genotype-phenotype 16%
• Trial-ready Cohort 16%
• Estimated numbers 16%
• Gene-targeted Therapy 16%
• Pathogenicity 16%
• Quality Check 16%
• Gene Targeting 16%
• Clinical Stratification 16%
• Characterization Data 16%
• Genetic Stratification 16%
• Targeted Clinical Trials 16%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• LRRK2 42%
• PINK1 42%
• VPS35 42%
• Clinical Trial 28%